BA
Balyasny Asset Management L.P. cut its CBIO stake below 5%
Balyasny Asset Management L.P. reported owning 4.3% of Crescent Biopharma, Inc. (CBIO) (1,611,958 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G